Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuaki Takeji

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
The American Journal of Cardiology|September 9, 2021
Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary InterventionKo Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
Circulation Reports|January 12, 2026
Hokuriku-plus Heart Failure Registry Study　- Rationale and Study DesignYasuaki Takeji, Masaya Shimojima, Akihiro Nomura, et al.
Circulation Reports|March 11, 2026
Clinical Trial on the Usefulness of an Intensive Low-Density Lipoprotein Cholesterol Treatment and Familial Hypercholesterolemia Screening Clinical Pathway for Acute Coronary Syndrome: The Hokuriku-plus Acute Coronary Syndrome Registry Study　- Rationale and Study DesignHayato Tada, Yasuaki Takeji, Chiaki Goten, et al.
The American Journal of Cardiology|January 17, 2021
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3)Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 9, 2022
Sex Differences in Clinical Outcomes After Percutaneous Coronary InterventionYasuaki Takeji, Takeshi Morimoto, Hiroki Shiomi, et al.
JACC. Cardiovascular Interventions|December 21, 2024
Low-Gradient Severe Aortic Stenosis: Insights From the CURRENT AS Registry-2Tomohiko Taniguchi, Takeshi Morimoto, Yasuaki Takeji, et al.
The Annals of Thoracic Surgery|February 4, 2023
Life Expectancy of Patients With Severe Aortic Stenosis in Relation to Age and Surgical Risk ScoreTomohiko Taniguchi, Takeshi Morimoto, Kyohei Yamaji, et al.
Cardiovascular Intervention and Therapeutics|March 3, 2026
Cardiac damage stages and prognosis in patients with bicuspid versus tricuspid aortic valve: insights from the CURRENT AS Registry-2Wataru Saitoh, Tomohiko Taniguchi, Yasuaki Takeji, et al.
Journal of the American Heart Association|July 29, 2021
Effect of Heart Failure on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery DiseaseKo Yamamoto, Yukiko Matsumura-Nakano, Hiroki Shiomi, et al.
Cardiovascular Intervention and Therapeutics|December 17, 2025
Low-flow and normal-flow low-gradient aortic stenosis with reduced left ventricular ejection fraction. Insights from the CURRENT AS Registry-2Tomohiko Taniguchi, Takeshi Morimoto, Yasuaki Takeji, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
The American Journal of Cardiology|September 9, 2021
Effect of Polypharmacy on Long-Term Mortality After Percutaneous Coronary InterventionKo Yamamoto, Masahiro Natsuaki, Takeshi Morimoto, et al.
Circulation Reports|January 12, 2026
Hokuriku-plus Heart Failure Registry Study　- Rationale and Study DesignYasuaki Takeji, Masaya Shimojima, Akihiro Nomura, et al.
Circulation Reports|March 11, 2026
Clinical Trial on the Usefulness of an Intensive Low-Density Lipoprotein Cholesterol Treatment and Familial Hypercholesterolemia Screening Clinical Pathway for Acute Coronary Syndrome: The Hokuriku-plus Acute Coronary Syndrome Registry Study　- Rationale and Study DesignHayato Tada, Yasuaki Takeji, Chiaki Goten, et al.
The American Journal of Cardiology|January 17, 2021
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3)Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 9, 2022
Sex Differences in Clinical Outcomes After Percutaneous Coronary InterventionYasuaki Takeji, Takeshi Morimoto, Hiroki Shiomi, et al.
JACC. Cardiovascular Interventions|December 21, 2024
Low-Gradient Severe Aortic Stenosis: Insights From the CURRENT AS Registry-2Tomohiko Taniguchi, Takeshi Morimoto, Yasuaki Takeji, et al.
The Annals of Thoracic Surgery|February 4, 2023
Life Expectancy of Patients With Severe Aortic Stenosis in Relation to Age and Surgical Risk ScoreTomohiko Taniguchi, Takeshi Morimoto, Kyohei Yamaji, et al.
Cardiovascular Intervention and Therapeutics|March 3, 2026
Cardiac damage stages and prognosis in patients with bicuspid versus tricuspid aortic valve: insights from the CURRENT AS Registry-2Wataru Saitoh, Tomohiko Taniguchi, Yasuaki Takeji, et al.
Journal of the American Heart Association|July 29, 2021
Effect of Heart Failure on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Severe Coronary Artery DiseaseKo Yamamoto, Yukiko Matsumura-Nakano, Hiroki Shiomi, et al.
Cardiovascular Intervention and Therapeutics|December 17, 2025
Low-flow and normal-flow low-gradient aortic stenosis with reduced left ventricular ejection fraction. Insights from the CURRENT AS Registry-2Tomohiko Taniguchi, Takeshi Morimoto, Yasuaki Takeji, et al.
Pageof 7